“One of the areas of the third phase of research on our CoviVac vaccine for children involves studying how it works on volunteers who have been ill more than six months ago and have not yet encountered the virus, volunteers aged from three to 17 years.
The children will be divided into three age groups, and the research will be carried out gradually with a decrease in the age threshold.
We will not immediately address the youngest.
Initially, it will be a group of teenagers 17-12 years old, the second category - from 12 to six, and only then from six to three years old, ”Chernov said in an interview with Izvestia.
He noted that the vaccine will be tested at the bases of four medical institutions in Perm, Samara, the Moscow Region and St. Petersburg.
Earlier, the Russian Ministry of Health issued permission to conduct the third phase of clinical trials of the CoviVac coronavirus vaccine with the participation of children.
Director of the Center
Chumakova, Aidar Ishmukhametov, on the Russia 24 TV channel, said that the effectiveness of the CoviVac vaccine against the omicron strain of coronavirus, according to preliminary laboratory data, is about 62%.
Professor Nikolai Malyshev, in an interview with Nation News, commented on the possible development of the situation with the pandemic.